EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 12 (Décembre 2021) Med Sci (Paris), 37 12 (2021) 1146-1157 Références
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 12, Décembre 2021
Vésicules extracellulaires
Page(s) 1146 - 1157
Section Vésicules extracellulaires
DOI https://doi.org/10.1051/medsci/2021207
Publié en ligne 20 décembre 2021
  1. Verma M, Lam TK, Hebert E, et al. Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology. BMC Clin Pathol 2015 ; 15 : [CrossRef] [PubMed] [Google Scholar]
  2. Saint-Pol J, Gosselet F, Duban-Deweer S, et al. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles. Cells 2020; 9 : 851. [CrossRef] [Google Scholar]
  3. Wiklander OPB, Brennan MÁ, Lötvall J, et al. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 2019; 11 : eaav8521. [CrossRef] [PubMed] [Google Scholar]
  4. Nagelkerke A, Ojansivu M, Koog L van der, et al. Extracellular vesicles for tissue repair and regeneration: evidence, challenges and opportunities. Adv Drug Deliv Rev 2021; 175 : 113775. [CrossRef] [PubMed] [Google Scholar]
  5. Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev 2020; 159 : 332–43. [CrossRef] [PubMed] [Google Scholar]
  6. Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J Extracell Vesicles 2015; 4. [Google Scholar]
  7. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018 ; 7 : 1535750. [CrossRef] [PubMed] [Google Scholar]
  8. Rohban R, Pieber TRMesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential. Stem Cells Int 2017 ; 2017 : e5173732. [CrossRef] [Google Scholar]
  9. Grangier A, Branchu J, Volatron J, et al. Technological advances towards extracellular vesicles mass production. Adv Drug Deliv Rev 2021; 113843. [CrossRef] [PubMed] [Google Scholar]
  10. Piffoux M, Nicolás-Boluda A, Mulens-Arias V, et al. Extracellular vesicles for personalized medicine: The input of physically triggered production, loading and theranostic properties. Adv Drug Deliv Rev 2019 ; 138 : 247–258. [CrossRef] [PubMed] [Google Scholar]
  11. Anne-Clémence Vion, Bhama Ramkhelawon, Xavier Loyer, et al. Shear Stress Regulates Endothelial Microparticle Release. Circul Res 2013 ; 112 : 1323–1333. [CrossRef] [PubMed] [Google Scholar]
  12. Pinto A, Marangon I, Méreaux J, et al. Immune Reprogramming Precision Photodynamic Therapy of Peritoneal Metastasis by Scalable Stem-Cell-Derived Extracellular Vesicles. ACS Nano 2021; 15 : 3251–63. [CrossRef] [PubMed] [Google Scholar]
  13. Berger A, Araújo-Filho I, Piffoux M, et al. Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula. Nanoscale 2021; 13 : 218–32. [CrossRef] [PubMed] [Google Scholar]
  14. Aubertin K, Silva AKA, Luciani N, et al. Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy. Sci Rep 2016 ; 6 : 35376. [CrossRef] [PubMed] [Google Scholar]
  15. Keklikoglou I, Cianciaruso C, Güç E, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol 2019 ; 21 : 190–202. [CrossRef] [PubMed] [Google Scholar]
  16. Gauthier NC, Fardin MA, Roca-Cusachs P, et al. Temporary increase in plasma membrane tension coordinates the activation of exocytosis and contraction during cell spreading. Proc Natl Acad Sci U S A 2011 ; 108 : 14467–14472. [CrossRef] [PubMed] [Google Scholar]
  17. Bodin P, Burnstock GEvidence That Release of Adenosine Triphosphate From Endothelial Cells During Increased Shear Stress Is Vesicular. J Cardiovasc Pharmacol 2001 ; 38 : 900–908. [CrossRef] [PubMed] [Google Scholar]
  18. de Jong OG, Verhaar MC, Chen Y, et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 2012 ; 1 : 18396. [CrossRef] [Google Scholar]
  19. Park K-S, Bandeira E, Shelke GV, et al. Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2019 ; 10 : 288. [CrossRef] [PubMed] [Google Scholar]
  20. Staubach S, Bauer FN, Tertel T, et al. Scaled preparation of extracellular vesicles from conditioned media. Adv Drug Deliv Rev 2021; 177 : 113940. [CrossRef] [PubMed] [Google Scholar]
  21. Gupta D, Maria Zickler A, EL Andaloussi S. Dosing Extracellular Vesicles. Adv Drug Deliv Rev 2021; 113961. [CrossRef] [PubMed] [Google Scholar]
  22. Bonsergent E, Grisard E, Buchrieser J, et al. Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat Commun 2021; 12 : 1864. [CrossRef] [PubMed] [Google Scholar]
  23. van Balkom BWM, Gremmels H, Giebel B, et al. Proteomic Signature of Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles. Proteomics 2019 ; 19 : 1800163. [CrossRef] [Google Scholar]
  24. Sebbagh AC, Rosenbaum B, Péré G, et al. Regenerative medicine for digestive fistulae therapy: benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 2021; 113841. [CrossRef] [PubMed] [Google Scholar]
  25. Maumus M, Pers Y-M, Ruiz M, et al. Cellules souches mésenchymateuses et médecine régénératrice - Quel avenir pour l’arthrose ?. Med Sci (Paris) 2018 ; 34 : 1092–1099. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  26. Kordelas L, Rebmann V, Ludwig A-K, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014 ; 28 : 970–973. [CrossRef] [PubMed] [Google Scholar]
  27. Doeppner TR, Herz J, Görgens A, et al. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med 2015 ; 4 : 1131–1143. [CrossRef] [PubMed] [Google Scholar]
  28. Liao Z, Liu H, Ma L, et al. Engineering Extracellular Vesicles Restore the Impaired Cellular Uptake and Attenuate Intervertebral Disc Degeneration. ACS Nano 2021; 15(9) : 14709–24. [CrossRef] [PubMed] [Google Scholar]
  29. Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010 ; 4 : 214–222. [CrossRef] [PubMed] [Google Scholar]
  30. Clement O, Cellier C, Wilhelm C, et al. Compositions useful for mucosal healing. WO/2018/011192. [Google Scholar]
  31. Silva AKA, Perretta S, Perrod G, et al. Thermoresponsive Gel Embedded with Adipose Stem-Cell-Derived Extracellular Vesicles Promotes Esophageal Fistula Healing in a Thermo-Actuated Delivery Strategy. ACS Nano 2018 ; 12 : 9800–9814. [CrossRef] [PubMed] [Google Scholar]
  32. Berger A, Caudron E, Perrod G, et al. Enhancing digestive fistula healing by the off-label use of a thermoresponsive vessel occluder polymer associated with esophageal stent placement: A case report. Clin Res Hepatol Gastroenterol 2021; 45 : 101474. [CrossRef] [PubMed] [Google Scholar]
  33. Coffin E, Grangier A, Perrod G, et al. Extracellular vesicles from adipose stromal cells combined with a thermoresponsive hydrogel prevent esophageal stricture after extensive endoscopic submucosal dissection in a porcine model. Nanoscale 2021; 13 : 14866–78. [CrossRef] [PubMed] [Google Scholar]
  34. Kervadec A, Bellamy V, El Harane N, et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant 2016 ; 35 : 795–807. [Google Scholar]
  35. Gao L, Wang L, Wei Y, et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci Transl Med 2020; 12 : eaay1318. [CrossRef] [PubMed] [Google Scholar]
  36. El Harane N, Kervadec A, Bellamy V, et al. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors. Eur Heart J 2018 ; 39 : 1835–1847. [CrossRef] [PubMed] [Google Scholar]
  37. Lima Correa B, El Harane N, Gomez I, et al. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts. Cardiovascul Res 2021; 117 : 292–307. [CrossRef] [PubMed] [Google Scholar]
  38. Cosenza S, Ruiz M, Toupet K, et al. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep 2017 ; 7 : 16214. [CrossRef] [PubMed] [Google Scholar]
  39. Cosenza S, Toupet K, Maumus M, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics 2018 ; 8 : 1399–1410. [CrossRef] [PubMed] [Google Scholar]
  40. Rozier P, Maumus M, Maria ATJ, et al. Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p. J Autoimmun 2021; 121 : 102660. [CrossRef] [PubMed] [Google Scholar]
  41. Warnecke A, Prenzler N, Harre J, et al. First-in-human intracochlear application of human stromal cell-derived extracellular vesicles. J Extracell Vesicles 2021; 10 : e12094. [CrossRef] [PubMed] [Google Scholar]
  42. Warnecke A, Harre J, Staecker H, et al. Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo. Clin Transl Med 2020; 10 : e262. [CrossRef] [PubMed] [Google Scholar]
  43. Piffoux M, Volatron J, Cherukula K, et al. Engineering and loading therapeutic extracellular vesicles for clinical translation: a data reporting frame for comparability. Adv Drug Deliv Rev 2021; 113972. [CrossRef] [PubMed] [Google Scholar]
  44. Piffoux M, Silva AKA, Wilhelm C, et al. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. ACS Nano 2018 ; 12 : 6830–6842. [CrossRef] [PubMed] [Google Scholar]
  45. Toledano Furman NE, Lupu-Haber Y, Bronshtein T, et al. Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform. Nano Lett 2013 ; 13 : 3248–3255. [CrossRef] [PubMed] [Google Scholar]
  46. Silva AKA, Kolosnjaj-Tabi J, Bonneau S, et al. Magnetic and Photoresponsive Theranosomes: Translating Cell-Released Vesicles into Smart Nanovectors for Cancer Therapy. ACS Nano 2013 ; 7 : 4954–4966. [CrossRef] [PubMed] [Google Scholar]
  47. Yakavets I, Francois A, Lamy L, et al. Effect of stroma on the behavior of temoporfin-loaded lipid nanovesicles inside the stroma-rich head and neck carcinoma spheroids. J Nanobiotech 2021; 19 : 3. [CrossRef] [Google Scholar]
  48. Jang SC, Economides KD, Moniz RJ, et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun Biol 2021; 4 : 1–17. [CrossRef] [PubMed] [Google Scholar]
  49. Chanut R, Petrilli VDétection de l’ADN cytosolique par la voie cGAS-STING - De l’immunité innée vers le contrôle de la tumorigenèse. Med Sci (Paris) 2019 ; 35 : 527–534. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  50. Camargo LCB de, Guaddachi F, Bergerat D, et al. Extracellular vesicles produced by NFAT3-expressing cells hinder tumor growth and metastatic dissemination. Sci Rep 2020; 10 : 8964. [CrossRef] [PubMed] [Google Scholar]
  51. Perets N, Oron O, Herman S, et al. Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B. Molecular Autism 2020; 11 : 65. [CrossRef] [PubMed] [Google Scholar]
  52. Seras-Franzoso J, Díaz-Riascos ZV, Corchero JL, et al. Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders. J Extracell Vesicles 2021; 10 : e12058. [CrossRef] [PubMed] [Google Scholar]
  53. Silva AKA, Morille M, Piffoux M, et al. Development of extracellular vesicle-based medicinal products: a position paper of the group Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France. Adv Drug Deliv Rev 2021; 179 : 114001. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.